Advancing genomics through research, technology and AI
A comprehensive innovation ecosystem spanning molecular genetics, cancer genomics, bioinformatics, multi-omics and precision medicine.
Core research domains
Pioneering molecular genetics, cancer genomics, NGS, RNA‑Seq, bioinformatics, multi‑omics and precision medicine.
Molecular Genetics
Gene regulation, variant discovery and functional validation in rare and complex disorders.
Cancer Genomics
Tumor profiling, driver mutation analysis and precision oncology biomarker discovery.
NGS & RNA‑Seq
End‑to‑end experimental design, QC, alignment, quantification and differential expression.
Bioinformatics
Pipeline engineering, statistical modeling and biological interpretation of large‑scale genomic data.
Multi‑Omics Integration
Combining genomics, transcriptomics, proteomics and metabolomics for systems biology insights.
Precision Medicine
Translating genomic findings into personalized diagnostics and targeted therapeutic strategies.
Platforms & infrastructure
Building the computational, experimental and automation backbone that powers our research pipeline.
Computational Platforms
Building scalable cloud‑based bioinformatics infrastructure for reproducible research.
Data Ecosystems
Integrating public and proprietary datasets into unified knowledge graphs for discovery.
In‑House Assay Development
Designing novel molecular assays and protocols tailored to regional disease burdens.
High‑Throughput Automation
Automating sample prep, sequencing workflows and QC pipelines for speed and consistency.
Product pipeline
From genomic kits and AI software to SaaS platforms — products designed for impact and scale.
Novel Genomic Kits
Diagnostic and research kits for targeted gene panels, pharmacogenomics and liquid biopsy.
AI‑Powered Software
Predictive tools for variant classification, biomarker scoring and clinical decision support.
Scientific SaaS Platforms
Subscription‑based analysis portals for hospitals, biotechs and academic consortia.
Our knowledge-based company roadmap
A strategic trajectory from scientific foundation to commercialization, aligned with national frameworks and global best practices.
Scientific Foundation
Peer‑reviewed research, reproducible methods and transparent data as the bedrock of value creation.
Knowledge‑Based Certification
Formal recognition under national knowledge‑based company frameworks to unlock growth funding.
International Partnerships
Strategic alliances with global genomics consortia, universities and pharmaceutical companies.
Commercialization Pipeline
From invention disclosure to product launch — a disciplined pathway for IP and market entry.
Next‑generation science
Pushing boundaries in gene therapy, synthetic biology, spatial omics and translational cohort design.
Gene & Cell Therapy
Exploring CRISPR‑based editing and autologous cell therapies for hematologic and solid tumors.
Synthetic Biology
Engineering genetic circuits and synthetic promoters for programmable therapeutic responses.
Spatial Omics
Mapping gene expression within tissue architecture to understand tumor microenvironments.
Translational Cohorts
Prospective clinical cohorts designed from the ground up with genomic stratification endpoints.
Intelligence at the core of discovery
Deep learning, generative models and automated pipelines that accelerate variant discovery, biomarker validation and therapeutic design.
Deep Variant Scoring
Neural networks trained on functional annotations to prioritize pathogenic variants at scale.
Generative Models for Sequence Design
Using transformers and diffusion models to design synthetic regulatory elements and guide RNAs.
Multi‑Modal Data Fusion
Fusing imaging, clinical notes and omics into unified embeddings for holistic patient modeling.
Automated Pipeline Intelligence
Self‑optimizing QC, alignment and quantification workflows that adapt to data characteristics.
Building an intellectual property moat
Protecting inventions, data assets and analytical methods through patents, trade secrets and strategic licensing.
Patent Portfolio Strategy
Systematic invention harvesting, prior‑art analysis and prosecution strategy across key markets.
Trade Secrets & Data Assets
Protecting proprietary datasets, trained models and analytical methods as competitive moats.
Licensing & Spin‑Outs
Structured licensing pathways and spin‑out ventures to monetize IP and amplify impact.
Join us in shaping the future of genomics.
Whether you are a researcher, clinician, investor or industry partner — we welcome collaboration.